#South Korea #Seoul #healthcare #Harvest #Desilo

Desilo to Launch HARVEST™: Transforming Healthcare Research

Desilo Inc., a pioneering startup in privacy technology, is gearing up to unveil its innovative platform, HARVEST™, in December 2025. This new platform aims to revolutionize the way medical institutions and pharmaceutical companies collaborate on research while ensuring patient data remains confidential. As healthcare continues to demand more robust data sharing capabilities, HARVEST™ seeks to alleviate the challenges posed by privacy regulations and security concerns.

In the realm of medical research, accessing robust datasets from multiple institutions is often essential. However, existing privacy regulations and the associated risks can impede the integration of valuable data. According to IBM, the repercussions of a healthcare data breach can average around $10.93 million, with violations of the General Data Protection Regulation (GDPR) leading to potential fines of up to €20 million. Desilo aims to address these concerns through HARVEST™ by implementing advanced technologies such as Fully Homomorphic Encryption (FHE) and Federated Learning (FL). These features will empower institutions to analyze data collaboratively and train models without ever needing to expose raw patient information.

Particularly, HARVEST™ is expected to drastically reduce research timelines, enabling studies that would traditionally take months to be completed in as little as a week. The platform facilitates both horizontal and vertical FL, split learning, and cohort federation. Moreover, it automatically addresses compliance requirements, ensuring alignment with GDPR and the Health Insurance Portability and Accountability Act (HIPAA).

Seungmyung Lee, the CEO of Desilo, highlighted the platform's mission: "Pharmaceutical companies and research consortia often face a trade-off between privacy and progress. Our goal is to shorten research timelines and reduce development costs, ultimately expediting drug development and diagnoses without compromising patient privacy."

Desilo's innovative technology has already garnered significant attention and accolades. The startup was awarded first place at iDASH, a prestigious international competition focused on privacy-preserving genomics. Additionally, it has developed a production-grade FHE library, showcasing its capabilities in cryptography. Collaborating with Cornami, a U.S.-based hardware innovator, Desilo also introduced the world's first commercial-scale encrypted large language model, significantly enhancing the performance of homomorphic encryption through GPU acceleration.

Furthermore, Desilo’s efforts are being recognized through participation in various government-backed initiatives, such as Korea's National Cancer Center Safe Data Zone Project, underlining the platform's strategic importance in the landscape of healthcare data security.

The highly anticipated HARVEST™ platform is set to launch in December, with early demonstration access available for interested parties. Desilo's forward-thinking approach not only enhances the potential for collaborative research in healthcare but also sets a new standard for privacy-preserving technologies in the industry, promising a safer future for patient information.

For more information or early access to HARVEST™, interested parties can reach out to Desilo via [email protected].